To determine whether Jnk2 and Jnk3 are required for JUN phosphorylation and RGC death in glaucoma, we assessed pJUN immunoreactivity and RGC soma loss in D2.Jnk2−/−Jnk3−/− mice. This evidence concerns the gene MAPK9 and glaucoma.